🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

From the Cristofanilli CTC Laboratory Lab to #ASCO25! 🧬 International Society of Liquid Biopsy YC Chair Carolina Reduzzi is presenting an outstanding poster on circulating tumor cells (CTCs) and estrogen receptor expression. Don’t miss it! #BreastCancer #Abstract1054 ASCO

Come meet our president, Christian Rolfo from おすし! He will be at our booth today from 2:30 PM to 3:15 PM. 🕑 Don’t miss the chance to engage with him and learn more about our society and the liquid biopsy world! 🩸 #Booth12041 at #ASCO25 ASCO

Excited to present our research today at #ASCO25 ASCO! IMG exhibit higher research productivity compared to AMGs - matrix that helps PDs to recruit more IMGs to hemonc fellowship programs! IMG Oncologists Nazli Dizman Fatemeh Ardeshir, MD Ziad Bakouny, MD, MSc Toni Choueiri, MD Ohio State Medical Oncology

At #ASCO25, James CEO Kimryn Rathmell, MD, PhD, shares some quick thoughts on the future of the oncology field, and The James’ role as a leader in cancer care and research.

That’s a wrap on a fantastic #ASCO25 full of collaboration for a cancer free world! The James

Last day in #ASCO25! Do not miss the Ohio State Medical Oncology presentations and posters! The James The Ohio State University College of Medicine

Congrats Dr. Hsin-Jung Joyce Wu & team on their study showing how #gut_microbes influence #Tcell plasticity. Now in Nature Immunology ▶️ bit.ly/44ZGs79 @ohiostatemed, Ohio State Rheumatology, Pelotonia Institute for Immuno-Oncology 🧫🧠🦠

Here's a powerful #ASCO25 conversation on the future of cancer care between Kimryn Rathmell and our Editor-in-Chief, Dr. Robert Figlin. Insights from leaders at The James/Ohio State & Cedars-Sinai (via Oncology News Central) oncologynewscentral.com/video/oncology…

Great paper from our ISLB Young Committee! A huge effort to keep sharing #LiquidBiopsy knowledge through reviews and editorials after major conferences worldwide. Follow us for more LB updates and insights! 🌍🧬 #ISLB #sciencecommunication

We are hiring. Faculty Position - Spatial Immuno-Oncology Research, Pathologist - Pelotonia Institute for Immuno-Oncology The James nature.com/naturecareers/…

At #ASCO25, new CEO Kimryn Rathmell, MD, PhD, explained how The James’ comprehensive approach to care and research inspired her to lead Ohio State's work to create a cancer-free world.

Congrats to our promoted faculty to Associate and Full Professors of the Ohio State Medical Oncology !! Your commitment, dedication and contributions are exceptional. The Ohio State University College of Medicine The James

Thanks for the kind interview. It’s an honor to serve our community and lead an exceptional Division of Medical Oncology with an outstanding group of clinicians, basic and translational researchers. The James Ohio State Medical Oncology The Ohio State University College of Medicine RolfoLab

What do cancer researchers do on a day off? Farmers market! (Healthy eating + exercise = ⬇️ cancer) There we found the BuckeyeThon students out raising awareness and support for pediatric blood cancers 🩸. Excellent energy! #EndCancer

🚨Our paper in Clinical Cancer Research is out “Liquid and Tissue Biopsies for Identifying MET Exon 14 Skipping NSCLC : Analyses from the Phase II VISION trial of Tepotinib” important #liquidbiopsy application METCrusaders The James Ohio State Medical Oncology RolfoLab AACR International Society of Liquid Biopsy

Lung MAP annual update at ASCO25 -Meeting the "unmet needs" with 3 active trials in MET space. Lung-MAP National Cancer Institute Foundation for the National Institutes of Health

Congrats M JOSE SERRANO Lab (LB&Cancer Interception group) and all the great team for this important initiative educating the new generation of scientists in molecular oncology! GENYO

Congrats to Logan Roof, MD & Lingbin Meng on being selected to attend the 2025 ASCO/AACR Methods in Clinical Cancer Research Workshop! Their IITs focus on SCLC and prostate cancer symptom management, respectively. Proud of our rising clinical researchers! ASCO AACR The James

📝New publication from our #GI medical oncologists & colleagues: Riluzole in Combination with mFOLFOX6 and Bevacizumab in Treating Patients with Metastatic Colorectal Cancer: A Phase I Clinical Trial Anne Noonan Ashish Manne Shafia Rahman doi.org/10.1158/1078-0…

Christian Rolfo, MD, PhD, brings a world of experience to his role as director of the Division of Medical Oncology Ohio State. health.osu.edu/health/cancer/…